← Leaderboards
Timothy David Le Cras
Cincinnati Childrens Hosp Med Ctr
$5,210,029
Attributed
$6,477,807
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $618.3K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,477,807 · 3
By mechanism
R01$6,477,807 · 3
Top collaborators
- Gurjit K Khurana Hershey5 shared
Most similar at Cincinnati Childrens Hosp Med Ctr
Same institution · by research overlap
- Elisa Boscolo$6,135,991
- Tesfaye B. Mersha$8,189,703
- Tanya Kalin$7,313,192
- Marc E. Rothenberg$46,535,760
- Denise Martin Adams$2,577,396
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsRegulationChildAffectSignal TransductionMorphogenesisResponseIn VitroExperimental ModelsLungStructureSymptomsPathogenesisParacrineLung DevelopmentAutocrineMediator Of Activation ProteinCellsAirway InflammationAirway Goblet Cell HyperplasiaAdvisory CommitteesAir PollutionAnimal ModelAir Pollutants
Grant awards (13)
Pathogenesis and Treatment of Kaposiform Lymphangiomatosis$618,343
R01 · FY2025 · HL · contact PI
Pathogenesis and Treatment of Kaposiform Lymphangiomatosis$605,976
R01 · FY2024 · HL · contact PI
Pathogenesis and Treatment of Kaposiform Lymphangiomatosis$618,343
R01 · FY2023 · HL · contact PI
Pathogenesis and Treatment of Kaposiform Lymphangiomatosis$618,343
R01 · FY2022 · HL · contact PI
Impact of Early Life Diesel Exposure Immune Patterning & Lung Structure/Function$457,370
R01 · FY2013 · HL · contact PI
Impact of Early Life Diesel Exposure Immune Patterning & Lung Structure/Function$498,278
R01 · FY2012 · HL · contact PI
Impact of Early Life Diesel Exposure on Immune Patterning and Lung Structure/Func$515,659
R01 · FY2011 · HL · contact PI
Impact of Early Life Diesel Exposure on Immune Patterning and Lung Structure/Func$523,144
R01 · FY2010 · HL · contact PI
Impact of Early Life Diesel Exposure on Immune Patterning and Lung Structure/Func$541,105
R01 · FY2009 · HL · contact PI
Role of TGF-Alpha in Pulmonary Vascular Disease$363,746
R01 · FY2006 · HL · contact PI
Role of TGF-Alpha in Pulmonary Vascular Disease$372,500
R01 · FY2005 · HL
Role of TGF-Alpha in Pulmonary Vascular Disease$372,500
R01 · FY2004 · HL
Role of TGF-Alpha in Pulmonary Vascular Disease$372,500
R01 · FY2003 · HL